α-MSH (11-13) is a peptide consisting of three amino acids, including the amino acids Alanine, Methionine, and Serine.
CAT No: 10-101-311
CAS No:67727-97-3
Synonyms/Alias:67727-97-3;Lys-pro-val;L-Valine, N-(1-L-lysyl-L-prolyl)-;Msh (11-13);alpha-Msh (11-13);L-Lysyl-L-prolyl-L-valine;ACTH-(11-13);(2S)-2-[[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoic acid;N-[Hydroxy(1-lysylpyrrolidin-2-yl)methylidene]valine;alpha-Msh (11-13) (free acid) acetate salt;Lysyl-prolyl-valine;alpha-MSH (11-13) (free acid);DTXSID80987067;CHEBI:160254;AKOS040753155;FM109220;
Chemical Name:(2S)-2-[[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoic acid
1. The spatiotemporal control of signalling and trafficking of the GLP-1R
2. High fat diet and GLP-1 drugs induce pancreatic injury in mice
3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.